J Atherosclerosis Prev Treat. 2022 Jan-Apr;13(1):17-25 | doi:10.53590/japt.02.1030 REVIEW ARTICLE Evangelia S. Makri, Stergios A. Polyzos First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece Abstract Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting millions of people worldwide with potentially serious complications that may lead to […]
Tag Archives: treatment
Diagnosis of hypertension in children and adolescents: 2019 update
Stella Stabouli, Vasileios Kotsis
Is non-alcoholic steatohepatitis in lean people a risk factor for liver or cardiovascular disease?
Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas, Georgios Sfikas, Charalambos Koumaras, Niki Katsiki, Vasilios Athyros
Non-alcoholic fatty liver disease in HIV – infected patients without viral hepatitis What can we do about their cardiovascular risk
G. Sfikas, Chr. Boutari, K. Tassios, K. Kaitanidis, E. Mitsiou, V.G. Athyros
Non-alcoholic fatty liver disease in HIV-infected patients without viral hepatitis. What can we do about their cardiovascular risk?
Georgios Sfikas, Chrysoula Boutari, Konstandinos Tassios, Konstantinos Kaitanidis, Eydoxia Mitsiou, Vasilios G. Athyros